Announcement

Collapse
No announcement yet.

Welcome to our forum! Before posting your questions, please read the following terms:

  1. 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
  2. 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
  3. 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
  4. 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.

By posting to the forums, you acknowledge and agree to these terms.

The InfantRisk team

Tolvaptan

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • #1

    Tolvaptan

    A mother of a 3 m.old is asking about the safety of tolvaptan (for her genetic renal polycystic syndrome) during breastfeeding.
    Do you have any data about it?
    thank you
    annalisa
    Tags: None
  • #2
    Annalisa:

    There's no data in breastfeeding mothers. This drug drastically increase sodium levels in plasma and therefore water content. I'd suggest it is too dangerous to use in a breastfeeding mother. While I would suggest milk level will be low, sodium retention in the infant could be significant.

    I'd suggest the risk is higher than the benefit of breastfeeding.

    Tom Hale Ph.D.

    Comment

    • #3
      Dr Hale,thank you for your quick and useful answer.
      Annalisa

      Comment

      Previous template Next
      Working...
      X